Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesNo recent work listed

Razmik Ghukasyan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1795-1892; OpenAlex author ID A5036481001. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 4

  1. MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling. Co-author DOI 10.1158/1078-0432.ccr-22-3322↗
  2. NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition. Co-author DOI 10.1073/pnas.2012469118↗
  3. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. Co-author DOI 10.1073/pnas.1812410116↗
  4. Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. Co-author DOI 10.18632/oncotarget.13572↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy R. Donahue · 4 shared papers, 2017–2023 · strength 0.38
  2. Caius Gabriel Radu · 4 shared papers, 2017–2023 · strength 0.38
  3. Evan R. Abt · 3 shared papers, 2019–2023 · strength 0.32
  4. Keke Liang · 2 shared papers, 2021–2023 · strength 0.25
  5. Irmina A. Elliott · 3 shared papers, 2017–2021 · strength 0.23
  6. Alexandra M. Moore · 2 shared papers, 2019–2021 · strength 0.17
  7. David W. Dawson · 2 shared papers, 2017–2021 · strength 0.16
  8. Joon Y. Park · 1 shared paper, 2023 · strength 0.15
  9. Jason M. Link · 1 shared paper, 2023 · strength 0.15
  10. Jing Cui · 1 shared paper, 2021 · strength 0.10
  11. Paul A. Toste · 1 shared paper, 2017 · strength 0.06
  12. Andrew Hieu Nguyen · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.